This title appears in the Scientific Report :
2012
Please use the identifier:
http://hdl.handle.net/2128/11529 in citations.
Please use the identifier: http://dx.doi.org/10.1159/000342480 in citations.
Discrepant MR and [18F]Fluoroethyl-L-Tyrosine PET imaging findings in a patient with bevacizumab failure
Discrepant MR and [18F]Fluoroethyl-L-Tyrosine PET imaging findings in a patient with bevacizumab failure
Photodynamic therapy (PDT) has become a well-established treatment for vascular forms of age-related macular degeneration (AMD). The implementation of evidence-based medicine principles into the treatment regimen of AMD seems to be immensly important, since AMD continues to be the most frequent caus...
Saved in:
Personal Name(s): | Galldiks, N. |
---|---|
Filss, C.P. / Goldbrunner, R. / Langen, K.-J. | |
Contributing Institute: |
Kognitive Neurowissenschaften; INM-3 Physik der Medizinischen Bildgebung; INM-4 |
Published in: | Case reports in oncology, 5 (2012) S. 490 - 494 |
Imprint: |
Basel
Karger
2012
|
Physical Description: |
490 - 494 |
DOI: |
10.1159/000342480 |
PubMed ID: |
17728549 |
Document Type: |
Journal Article |
Research Program: |
Funktion und Dysfunktion des Nervensystems |
Series Title: |
Case Reports in Oncology
5 |
Subject (ZB): | |
Link: |
Get full text OpenAccess OpenAccess |
Publikationsportal JuSER |
Please use the identifier: http://dx.doi.org/10.1159/000342480 in citations.
Photodynamic therapy (PDT) has become a well-established treatment for vascular forms of age-related macular degeneration (AMD). The implementation of evidence-based medicine principles into the treatment regimen of AMD seems to be immensly important, since AMD continues to be the most frequent cause of blindness among patients older than 65 years in industrialized countries. Numerous randomized prospective studies demonstrated high levels of evidence for the efficacy of various treatment approaches such as laser photocoagulation, PDT, subretinal surgery or novel anti-angiogenic drugs [Arch Ophthalmol 2006;124:597-599]. The high evidence shown by these studies supported the rationale to use PDT also in additional, less frequent, vasoproliferative diseases. Although these 'case series' and 'individual case control studies' have a low level of evidence, they give us important information for treatment decisions in these rare conditions. The goal of this survey is to review the current literature regarding PDT in vasoproliferative and exudative ocular diseases outside AMD. Many studies modified the treatment parameters of PDT to address the specific pathology of the underlying disease. Table 1 summarizes the diseases and treatment parameters that are described in this part 2, the entire table of this review is included in part 1 (www.karger.com/doi/10.1159/ 000101922). |